In terms of renin-angiotensin-aldosterone system–dependent hypertension, Nox2 inhibition would be anticipated to be beneficial, and combined Nox1/Nox2 inhibitors could be of particular value given the effects of both isoforms to increase BP. This evidence concerns the gene REN and Hypertension.